NCT06962722

Brief Summary

This healthy volunteer intervention study is designed to evaluate the effectiveness of upper limb motor control training (uMCT) on physical and cognitive functions in older adults. The primary objectives of the study are twofold: Assess the Impact on Physical and Neuromuscular Function: The study seeks to determine whether uMCT positively influences physical performance, including motor coordination and neuromuscular function, in older adults. Assessment the Impact on Cognitive Function: The study aims to investigate whether uMCT enhances cognitive abilities in older adults. In addition to these main goals, the study will also assess the feasibility and safety of implementing uMCT in an older adult population. The main questions it aims to answer are: Does uMCON training have a positive effect on physical function and neuromuscular function in older adults? Does uMCON training have a positive effect on cognitive function in older adults? The researchers designed this study to show whether uMCON training works on physical function (balance, gait, and so on) and cognition in older adults. Participants will come to Derby Royal Hospital Medical School to attend uMCON training three days a week for 1 month. They will attend pre-training, post-training, and follow-up (after 1 month) control assessment sessions.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
24

participants targeted

Target at below P25 for not_applicable

Timeline
0mo left

Started Sep 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress99%
Sep 2023May 2026

Study Start

First participant enrolled

September 1, 2023

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

September 27, 2024

Completed
7 months until next milestone

First Posted

Study publicly available on registry

May 8, 2025

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2026

Last Updated

May 8, 2025

Status Verified

April 1, 2025

Enrollment Period

2.7 years

First QC Date

September 27, 2024

Last Update Submit

April 29, 2025

Conditions

Keywords

neuromuscular trainingolder adultscognitive impairmentexercise

Outcome Measures

Primary Outcomes (1)

  • Outcome Measure Title: Rate of participants whose cognition improved with upper limb motor control training.

    Number of Participants: 20 Control group: No Rate of Female/Male: 50%/ 50% Time frame: 1 month upper limb neuromuscular training Assessment time: Pre-training, Post-training, Follow-up(after 4 weeks) Cognition questionnaire is used (MOCA).

    Baseline, 4 week, and 8 week

Secondary Outcomes (2)

  • Clinically relevant functional outcomes (motor control, strength, dexterity, overall physical function)

    Baseline, 4 week, and 8 week

  • Plasma pro/anti-inflammatory cytokine levels

    Baseline, 4 week, and 8 week

Study Arms (1)

Intervention Group

EXPERIMENTAL

uMCON training group

Other: Upper limb motor control training (uMCON)

Interventions

The exercise program protocol was determined using elbow flexion (Biceps brachii) and elbow extension (Triceps) on a special platform developed for the arm. In this computer-based exercise, participants are asked to follow a small ball on the screen in different lines at certain percentages of maximum muscle strength (10%, 25%, 50%, and so on). Neuromuscular training will be worked on with this exercise.

Intervention Group

Eligibility Criteria

Age65 Years - 85 Years
Sexall
Healthy VolunteersYes
Age GroupsOlder Adult (65+)

You may qualify if:

  • Willing and able to give informed consent for participation in the study
  • Aged between 65-85 years

You may not qualify if:

  • Diagnosis of cognitive impairment
  • Current or recent (\<5y) malignancy
  • History of or current psychiatric illness
  • History of or current neurological condition (e.g., epilepsy, Parkinsons disease, cerebrovascular disease)
  • Severe respiratory disease (e.g., uncontrolled asthma, COPD, pulmonary hypertension)
  • Active cardiovascular disease: Uncontrolled hypertension (BP\>160/100mmHg); Recent (\<12mo) cardiac event; Heart failure (Class III/IV); Significant arrhythmia; Unstable angina
  • Metabolic disease: Untreated hyper/hypo-parathyroidism; Cushing's disease; Type 1 or 2 diabetes
  • Significant musculoskeletal disorders (based on clinical opinion)
  • Family history of early (\<55y) death from cardiovascular disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The University of Nottingham Medical School

Derby, Derbyshire, DE22 3DT, United Kingdom

RECRUITING

MeSH Terms

Conditions

Cognitive DysfunctionMotor Activity

Condition Hierarchy (Ancestors)

Cognition DisordersNeurocognitive DisordersMental DisordersBehavior

Study Officials

  • Hatice Sirin Ekici, PhD

    The University of Nottingham

    STUDY DIRECTOR
  • Mehmet C Yildirim, PhD

    The University of Nottingham

    STUDY DIRECTOR

Central Study Contacts

Bethan E Phillips, Professor

CONTACT

Jemima Collins, Assist Prof

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

September 27, 2024

First Posted

May 8, 2025

Study Start

September 1, 2023

Primary Completion (Estimated)

May 31, 2026

Study Completion (Estimated)

May 31, 2026

Last Updated

May 8, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will not share

Access to personal (identifiable) information is limited only to research staff involved in the participation elements of this study, and to audit staff as detailed above.

Locations